University of Tasmania
Browse

File(s) under embargo

Krill Oil for Knee Osteoarthritis A Randomized Clinical Trial

journal contribution
posted on 2024-09-05, 05:05 authored by Laura LaslettLaura Laslett, Elisabeth ScheepersElisabeth Scheepers, Benny Eathakkattu AntonyBenny Eathakkattu Antony, Anita E Wluka, Guoqi CaiGuoqi Cai, Catherine L Hill, Lyn March, Helen I Keen, Petr OtahalPetr Otahal, Flavia M Cicuttini, Graeme JonesGraeme Jones
IMPORTANCE: Knee osteoarthritis is disabling, with few effective treatments. Preliminary evidence suggested that krill oil supplementation improved knee pain, but effects on knee osteoarthritis remain unclear. OBJECTIVE: To evaluate efficacy of krill oil supplementation, compared with placebo, on knee pain in people with knee osteoarthritis who have significant knee pain and effusion-synovitis. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized, double-blind, placebo-controlled clinical trial in 5 Australian cities. Participants with clinical knee osteoarthritis, significant knee pain, and effusion-synovitis on magnetic resonance imaging were enrolled from December 2016 to June 2019; final follow-up occurred on February 7, 2020. INTERVENTIONS: Participants were randomized to 2 g/d of krill oil (n = 130) or matching placebo (n = 132) for 24 weeks. MAIN OUTCOMES AND MEASURES: The primary outcome was change in knee pain as assessed by visual analog scale (range, 0-100; 0 indicating least pain; minimum clinically important improvement = 15) over 24 weeks. RESULTS: Of 262 participants randomized (mean age, 61.6 [SD, 9.6] years; 53% women), 222 (85%) completed the trial. Krill oil did not improve knee pain compared with placebo (mean change in VAS score, -19.9 [krill oil] vs -20.2 [placebo]; between-group mean difference, -0.3; 95% CI, -6.9 to 6.4) over 24 weeks. One or more adverse events was reported by 51% in the krill oil group (67/130) and by 54% in the placebo group (71/132). The most common adverse events were musculoskeletal and connective tissue disorders, which occurred 32 times in the krill oil group and 42 times in the placebo group, including knee pain (n = 10 with krill oil; n = 9 with placebo), lower extremity pain (n = 1 with krill oil; n = 5 with placebo), and hip pain (n = 3 with krill oil; n = 2 with placebo). CONCLUSIONS AND RELEVANCE: Among people with knee osteoarthritis who have significant knee pain and effusion-synovitis on magnetic resonance imaging, 2 g/d of daily krill oil supplementation did not improve knee pain over 24 weeks compared with placebo. These findings do not support krill oil for treating knee pain in this population. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry Identifier: ACTRN12616000726459; Universal Trial Number: U1111-1181-7087.

History

Sub-type

  • Article

Publication title

JAMA

Medium

Print-Electronic

Volume

331

Issue

23

Pagination

1997-2006:10

eISSN

1538-3598

ISSN

0098-7484

Department/School

Menzies Institute for Medical Research

Publisher

AMER MEDICAL ASSOC

Publication status

  • Published

Place of publication

United States

Event Venue

Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.

Rights statement

Copyright © 2024, American Medical Association

Usage metrics

    Menzies Institute for Medical Research

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC